Escient Pharmaceuticals, a clinical-stage drug development firm focused on developing innovative small molecule treatments for systemic neuro-inflammatory disorders, published encouraging results from a phase 1 first-in-human study of EP262,...
Telix Pharmaceuticals rose over 3 per cent this week to hit an all-time high, after the radiopharma firm said it would acquire UK-based medical device firm Lightpoint Medical....
Novo Holdings A/S, a leading global life sciences investor, announced that it has agreed to acquire Ellab from EQT Headquartered in Hillerød, Denmark, Ellab (Ellab) provides validation and monitoring solutions and services for biotech...
The Government of Maharashtra health department has inked a Memorandum of Understanding (MoU) with multinational pharmaceutical manufacturer Boehringer Ingelheim India to use Artificial Intelligence to improve stroke care at government...
The Indian Council of Medical Research (ICMR) has invited Expression of Interest (EOI) for Implementation Research Study on Ambulatory Care for Non-Communicable Diseases (NCDs) in Public Health Care Systems in India...
Zynex, Inc., an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has announced that the FDA has granted 510(k) market...
Udaya Bhaskar, Director General of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), a body under the Department of Commerce, predicted on Tuesday that Indian pharmaceutical exports could reach USD 28 billion in the current fiscal..
SK bioscience, a global innovative vaccine and biotech company dedicated to promoting human health from prevention to cure, announced that its Covid-19 vaccine, SKYCovione, has received the WHO Emergency Use Listing....
Mankind Pharma Ltd. has received the most analyst coverage of any new Indian stock in at least 12 years, as investors rush to purchase the drugmaker's shares following a blockbuster IPO in May. Since its initial public offering, the company's...
ldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, announced positive top-line results from the phase 3 INVIGORATE-2 clinical trial...
, CDSCO.jpg)
